Skip to main content
CORT logo

CORT · Corcept Therapeutics Inc · Analyst Estimates

Track CORT — free
$115.69 +0.95 (+0.83%) At close · Sep 30
Market Cap
$12.60B
Shares
108.10M
Volume · Sep 30 910.47K Avg daily vol (3M) 1.31M

Analyst Estimates

Compare analyst forecasts for Corcept Therapeutics Inc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 19:05 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
1.84
2.15
2.41
—
0.55667
0.4875
2.13333
0.4775
— — — —
EPS
analysts
Publication date not stated
— — —
4
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
1129200000
1146156000
1157900000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
1.85
4.4025
7.75
—
3.20667
2.495
4.51667
1.63
— — — —
EPS
analysts
Publication date not stated
— — —
4
— — — —
0
0
2
2
Revenue
USD
Publication date not stated
1534000000
1704901000
2061500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.74
0.865
1.03
—
0.25333
0.25333
0.85
0.25
— — — —
EPS
analysts
Publication date not stated
— — —
4
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
329480000
336370000
350000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
1.01
1.205
1.31
—
0.57667
0.57667
1.20333
0.56667
— — — —
EPS
analysts
Publication date not stated
— — —
4
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
378200000
388748500
402994000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —
Key facts CIK 1088856 CUSIP 218352102 13F (30d) 16 filings 12 filers Visit website Investor relations